Stockreport

Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis [Yahoo! Finance]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF Provides an additional treatment option without the need for IV facilities, expanding accessibility for patients SAN DIEGO June 25, 2024 /PRNewswire/ -- Halozyme Ther [Read more]